Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 21, 2025
Minibeam Radiation Therapy for Recurrent Mucosal Melanoma: An Eye-Opening ResponseMaddi A Jacobson, Yasamin Sharifzadeh, Arkadiusz Z Dudek, et al.Foot & Ankle International|August 28, 2020
Progressive Collapsing Foot Deformity: Consensus on Goals for Operative CorrectionBruce J Sangeorzan, Beat Hintermann, Cesar de Cesar Netto, et al.Foot & Ankle International|August 28, 2020
Consensus for the Use of Weightbearing CT in the Assessment of Progressive Collapsing Foot DeformityCesar de Cesar Netto, Mark S Myerson, Jonathan Day, et al.Foot & Ankle International|September 2, 2020
Titrating the Amount of Bony Correction in Progressive Collapsing Foot DeformityScott J Ellis, Jeffrey E Johnson, Jonathan Day, et al.Clinical Biomechanics (Bristol, Avon)|May 21, 2013
Kinetics and kinematics after the Bridle procedure for treatment of traumatic foot dropMary K Hastings, David R Sinacore, James Woodburn, et al.Annals of Surgical Oncology|May 30, 2026
Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) SubstudyTina J Hieken, Thomas J Flotte, David Zahrieh, et al.Annals of Surgical Oncology|July 2, 2024
Lymphedema Rates Following Axillary Lymph Node Dissection With and Without Immediate Lymphatic Reconstruction: A Prospective TrialJames W Jakub, Judy C Boughey, Tina J Hieken, et al.European Journal of Cancer (Oxford, England : 1990)|August 12, 2025
NeoACTIVATE Arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable Stage III melanomaTina J Hieken, David Zahrieh, Thomas J Flotte, et al.Current Oncology (Toronto, Ont.)|July 27, 2026
Real-World Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Treatment Delivery, Immune Reconstitution, and Cardiac Monitoring During High-Dose IL-2Mohamed A Aboelatta, Jabra Zarka, Nika Tchatchua, et al.Pageof 9